Case File №
#VI-2026-0467
Qingdao Saber Technology Pharma QST
Direct manufacturer & exporter based in Qingdao, China. Research peptides, SARMs, injectable oils and raw materials with published HPLC & mass-spec reports per batch. Official website: qingdaosabertech.com. 45 tests logged in the VendorInvestigator case file across 40 products. Grade C.
KNOWN ADDRESS: qingdaosabertech.com
Exhibit I
Compounds on File
40 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | C Okay | 7 | 6.5 | 4.7 | 10.0 | 3 Jun 2025 |
| Tirzepatide | E Bad | 4 | 6.2 | 0.0 | 9.5 | 2 Jul 2025 |
| Abaloparatide | X N/A | 1 | 5.9 | 5.9 | 5.9 | 2 Jul 2025 |
| ACE-031 | X N/A | 1 | 7.7 | 7.7 | 7.7 | 28 Mar 2025 |
| Andarine S4 | X N/A | 1 | 4.9 | 4.9 | 4.9 | 11 Jun 2025 |
| APAA (alpha-phenylacetoacetamide) CAS 102-01-2 | X N/A | 1 | 4.1 | 4.1 | 4.1 | 7 May 2025 |
| Blend 500 (Tren E/Mast E) | X N/A | 1 | 6.8 | 6.8 | 6.8 | 8 Jul 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 7.3 | 7.3 | 7.3 | 25 Apr 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 7.7 | 7.7 | 7.7 | 9 Jun 2025 |
| Cartalax | X N/A | 1 | 4.4 | 4.4 | 4.4 | 13 Jun 2025 |
| Chonluten | X N/A | 1 | 6.3 | 6.3 | 6.3 | 16 Mar 2025 |
| Clenbuterol | X N/A | 1 | 6.7 | 6.7 | 6.7 | 20 Jun 2025 |
| Crystagen | X N/A | 1 | 6.6 | 6.6 | 6.6 | 21 May 2025 |
| DHB (1-Test Cyp) Oral | X N/A | 1 | 6.3 | 6.3 | 6.3 | 16 Mar 2025 |
| Enclomiphene | X N/A | 1 | 6.4 | 6.4 | 6.4 | 14 Jan 2025 |
| EPO | X N/A | 1 | 7.5 | 7.5 | 7.5 | 6 May 2025 |
| GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | X N/A | 1 | 4.0 | 3.9 | 3.9 | 13 Jun 2025 |
| Halotestin (Fluoxymesterone) | X N/A | 1 | 5.4 | 5.4 | 5.4 | 21 May 2025 |
| HGH Fragment 176-191 | X N/A | 1 | 8.1 | 8.1 | 8.1 | 9 Jun 2025 |
| Humanin | X N/A | 1 | 8.0 | 8.0 | 8.0 | 27 Feb 2025 |
| Ivermectin | X N/A | 1 | 6.2 | 6.2 | 6.2 | 9 Jun 2025 |
| KissPeptin-10 | X N/A | 1 | 8.4 | 8.4 | 8.4 | 13 Jun 2025 |
| Livagen | X N/A | 1 | 5.4 | 5.4 | 5.4 | 2 Jul 2025 |
| MOTS-C | X N/A | 1 | 7.6 | 7.6 | 7.6 | 2 Apr 2025 |
| MT-1 | X N/A | 1 | 6.2 | 6.2 | 6.2 | 11 Jun 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 6.6 | 6.6 | 6.6 | 6 May 2025 |
| Nandrolone Decanoate (Deca) Raw | X N/A | 1 | 7.5 | 7.5 | 7.5 | 25 Apr 2025 |
| Ostarine (MK-2866) | X N/A | 1 | 6.2 | 6.2 | 6.2 | 20 Jun 2025 |
| Ovagen | X N/A | 1 | 5.9 | 5.9 | 5.9 | 11 Jun 2025 |
| Oxytocin Acetate | X N/A | 1 | 4.9 | 4.9 | 4.9 | 14 Jan 2025 |
| PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | X N/A | 1 | 8.9 | 8.9 | 8.9 | 24 Apr 2025 |
| Proviron (Mesterolone) Raw | X N/A | 1 | 5.8 | 5.8 | 5.8 | 16 Mar 2025 |
| PTD-DBM | X N/A | 1 | 4.0 | 4.0 | 4.0 | 8 Jul 2025 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | X N/A | 1 | 4.4 | 4.4 | 4.4 | 14 Jan 2025 |
| Semaglutide Raw | X N/A | 1 | 7.5 | 7.5 | 7.5 | 6 May 2025 |
| SR9009 | X N/A | 1 | 6.5 | 6.5 | 6.5 | 14 Jan 2025 |
| Testosterone Decanoate Raw | X N/A | 1 | 4.6 | 4.6 | 4.6 | 6 May 2025 |
| Thymalin | X N/A | 1 | 5.2 | 5.2 | 5.2 | 16 Mar 2025 |
| Vilon | X N/A | 1 | 5.9 | 5.9 | 5.9 | 2 Jul 2025 |
| Vitamin B12 10mg/ml | X N/A | 1 | 5.4 | 5.4 | 5.4 | 17 Dec 2024 |
Exhibit II
Evidence Log
45 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Vilon | 5.4 B | 30mg | 36.4mg | +21.5% | 99.20% | qft6fm | Lab E | Community |
| 24 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 7.5 A | 20mg | 18.6mg | -7.0% | 95.36% | fk0c6u | Lab E | Public |
| 24 May 2026 | KissPeptin-10 | 9.8 A | 5mg | 4.6mg | -8.0% | 97.77% | zclu9o | Lab A | Public |
| 24 May 2026 | MOTS-C | 4.8 C | 20mg | 23.0mg | +15.0% | 97.31% | zrr2me | Lab G | Public |
| 23 May 2026 | N-Acetyl Epitalon Amidate | 7.8 A | 30mg | 26.3mg | -12.5% | 98.56% | 6falux | Lab D | Public |
| 21 May 2026 | DHB (1-Test Cyp) Oral | 7.3 A | 50mg | 46.8mg | -6.3% | 97.60% | jdzijw | Lab A | Public |
| 20 May 2026 | Chonluten | 5.3 B | 20mg | 23.7mg | +18.7% | 95.53% | 7of7t0 | Lab F | Community |
| 19 May 2026 | SR9009 | 5.8 B | 50mg | 42.8mg | -14.3% | 95.27% | h5rmsw | Lab C | Public |
| 17 May 2026 | Enclomiphene | 4.0 C | 10mg | 10.9mg | +9.3% | 96.28% | glgmtr | Lab G | Public |
| 17 May 2026 | HGH Fragment 176-191 | 7.0 A | 2mg | 2.1mg | +5.1% | 98.15% | vn8t6j | Lab A | Community |
| 17 May 2026 | Humanin | 8.0 A | 20mg | 24.7mg | +23.7% | 98.26% | vc4p7f | Lab B | Community |
| 17 May 2026 | Thymalin | 4.0 C | 5mg | 6.0mg | +20.6% | 95.01% | meq1u9 | Lab A | Community |
| 29 Jan 2026 | Retatrutide 5mg + Cagrilintide 5mg Blend | 4.0 C | 15mg | 18.7mg | +24.7% | 99.62% | s42tz4 | Lab E | Public |
| 26 Jan 2026 | Blend 500 (Tren E/Mast E) | 6.3 A | 200mg/ml | 178.3mg/ml | -10.9% | 99.20% | ca9563 | Lab B | Public |
| 26 Jan 2026 | Crystagen | 5.0 B | 10mg | 9.0mg | -9.7% | 96.30% | 0nmk9k | Lab G | Community |
| 26 Jan 2026 | Livagen | 4.0 C | 20mg | 20.8mg | +4.0% | 99.24% | l9ruld | Lab G | Public |
| 26 Jan 2026 | Nandrolone Decanoate (Deca) Raw | 5.2 B | 100g | 85.2g | -14.8% | 96.94% | rlv5pe | Lab F | Community |
| 26 Jan 2026 | Ostarine (MK-2866) | 8.2 A | 10mg | 9.3mg | -7.0% | 99.91% | anobch | Lab F | Community |
| 9 Jan 2026 | Ovagen | 5.5 B | 5mg | 4.9mg | -2.4% | 96.87% | tn6jhx | Lab E | Community |
| 7 Jan 2026 | ACE-031 | 5.7 B | 30mg | 33.2mg | +10.8% | 98.45% | 70nf95 | Lab E | Community |
| 7 Jan 2026 | Clenbuterol | 6.0 A | 100mg | 97.0mg | -3.0% | 95.55% | a2qojy | Lab A | Public |
| 30 Dec 2025 | Tirzepatide | 7.3 A | 30mg | 34.1mg | +13.7% | 99.71% | T3025Ja01 | Lab E | Public |
| 29 Dec 2025 | Retatrutide | 7.8 A | 20mg | 22mg | +10.0% | 99.60% | R2025Ja01 | Lab G | Public |
| 29 Dec 2025 | Abaloparatide | 7.2 A | 15mg | 18.2mg | +21.6% | 95.79% | 3gacf9 | Lab B | Community |
| 29 Dec 2025 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 9.0 A | 10g | 10.9g | +8.7% | 98.85% | vs1qyq | Lab E | Public |
| 12 Dec 2025 | Ivermectin | 8.1 A | 100mg | 98.2mg | -1.8% | 95.45% | 5anltf | Lab D | Community |
| 12 Dec 2025 | Oxytocin Acetate | 4.0 C | 20mg | 18.7mg | -6.3% | 97.09% | coor2a | Lab F | Community |
| 11 Dec 2025 | Retatrutide | 10.0 A | 10mg | 10.4mg | +4.0% | 99.92% | R1025Ja01 | Lab E | Public |
| 11 Dec 2025 | Tirzepatide | 9.5 A | 60mg | 63.9mg | +6.5% | 99.95% | T6025Ja01 | Lab E | Public |
| 5 Dec 2025 | Testosterone Decanoate Raw | 4.0 C | 100g | 118.8g | +18.8% | 96.07% | nkt3fh | Lab C | Community |
| 23 Nov 2025 | Andarine S4 | 4.0 C | 100mg | 119.8mg | +19.8% | 96.91% | irxf65 | Lab E | Community |
| 23 Nov 2025 | APAA (alpha-phenylacetoacetamide) CAS 102-01-2 | 5.5 B | 1g | 1.0g | +1.4% | 98.68% | ncttmf | Lab E | Community |
| 23 Nov 2025 | Vitamin B12 10mg/ml | 6.0 A | 200mg/ml | 247.6mg/ml | +23.8% | 97.80% | pd3kcf | Lab D | Public |
| 5 Nov 2025 | Proviron (Mesterolone) Raw | 6.9 A | 1g | 1.2g | +20.6% | 97.29% | q3zovv | Lab B | Public |
| 4 Nov 2025 | EPO | 7.5 A | 50mg | 60.8mg | +21.6% | 98.38% | z7rm2p | Lab B | Community |
| 4 Nov 2025 | Halotestin (Fluoxymesterone) | 5.1 B | 100mg | 91.0mg | -9.0% | 95.49% | jeu6qq | Lab D | Public |
| 9 Oct 2025 | BPC157 5mg + TB500 5mg Blend | 8.4 A | 5mg | 5.9mg | +17.3% | 99.08% | wadcrf | Lab B | Public |
| 9 Oct 2025 | Cartalax | 4.0 C | 5mg | 5.0mg | +0.2% | 99.36% | z0h59r | Lab A | Public |
| 9 Oct 2025 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 4.0 C | 10mg | 9.5mg | -4.6% | 95.55% | dp53po | Lab C | Public |
| 9 Oct 2025 | PTD-DBM | 4.0 C | 30mg | 26.0mg | -13.4% | 98.16% | 6gofph | Lab C | Public |
| 9 Oct 2025 | Semaglutide Raw | 6.8 A | 100g | 102.0g | +2.0% | 96.67% | 8cg3gd | Lab D | Community |
| 3 Oct 2025 | MT-1 | 4.9 C | 20mg | 21.3mg | +6.6% | 96.57% | lgohtj | Lab G | Public |
| 1 Sep 2025 | Retatrutide | 4.7 D | 5mg | 5.68mg | +13.6% | 99.45% | (no batch ID) | Lab F | Public |
| 4 Aug 2025 | Retatrutide | 5.5 C | 10mg | 9.89mg | -1.1% | 98.52% | (no batch ID) | Lab E | Public |
| 25 Jul 2025 | Tirzepatide | 7.8 A | 30mg | 29.7mg | -1.0% | 99.82% | (no batch ID) | Lab E | Public |
— END OF EVIDENCE LOG —